Scientific interest in orthopoxvirus infections and search for new highly effective compounds possessing antiviral activity against orthopoxviruses have significantly increased as a result of worldwide mpox outbreak in 2022. The present work deals with the synthesis of new 2-arylimidazoles exhibiting in vitro activity not only against the vaccinia virus, cowpox virus and ectromelia (mousepox) virus but also against the variola virus. Among the imidazole derivatives under consideration (1-hydroxyimidazoles, 1-methoxyimidazoles, 1-benzyloxyimidazoles, and imidazole N-oxides), the most promising antiviral activity is demonstrated by 1-hydroxyimidazoles, which may exist as two prototropic tautomers. Both of these tautomers may be manifested in different crystal structures of these compounds, according to single-crystal X-ray diffraction analysis, while predominantly one of them (N-hydroxy-tautomeric form) is present in DMSO-d6 solutions and in the gaseous state, as shown by NMR spectroscopy and quantum-chemical calculations. The leader compound 1-hydroxy-2-(4-nitrophenyl)imidazole 4a demonstrated the highest selectivity indices against the vaccinia virus (SI = 1072) and the variola virus (SI = 373).
Structural features (isomers, tautomers, conformers) of N -substituted 2-(2-arylethenyl)imidazoles were considered. Antiviral activity against orthopoxviruses was evaluated, with 1-methoxyimidazoles being the most promising compounds.
1 December 2025 in Russian Journal of General Chemistry
The reduction of 1-hydroxydimiazole derivatives containing a nitrophenyl substituent was studied. Reduction of either 1-hydroxy-4,5-dimethyl-2-(4-nitrophenyl)imidazole or 1-hydroxy-4,5-dimethyl-2-[2-(4-nitrophenyl)ethenyl]imidazole with sodium dithionite promptly resulted in products of complete reduction, i.e., aniline-containing imidazoles with no additional substituents at the nitrogen atoms in positions 1 and 3 of the heterocycle. Two synthetic routes to 5-acetylimidazoles containing 2-(4-aminophenyl) or 2-[2-(4-aminophenyl)ethenyl] moieties with no substituents at the nitrogen atoms of the heterocycle were proposed. These compounds were obtained as by-products in the reduction reactions of starting 5-acetyl-1-hydroxyimidazole derivatives with either sodium dithionite in the presence of base in THF–H2O media or zinc in glacial acetic acid. Otherwise, these aminophenyl-containing 5-acetylimidazoles were synthesized by a two-step procedure including selective reduction of the hydroxyl group in position 1 of nitrophenyl-substituted imidazoles followed by the reduction of the nitro group of the substituent with sodium dithionite. The possibility of the acquisition of 5-acetyl-1-hydroxyimidazole derivatives containing a primary amino group in the aryl substituent was also demonstrated for the first time.
1 February 2025 in Russian Journal of General Chemistry
The predominant tautomer form of 5-ethoxycarbonyl-substituted 1-hydroxyimidazoles (exhibiting antiviral activity towards orthopoxviruses) in a solution of aprotic DMSO-d6 has been elucidated from the data of 1Н and 13С NMR spectroscopy in comparison with model structures. The IR spectra (KBr pellets) have been considered. It has been shown that 1-hydroxyimidazoles 3а, 3b predominantly exist as N-hydroxy tautomers in the solution, forming crystal hydrates in the solid state, in which water favors the shift of the tautomeric equilibrium towards the N-oxide.
1 November 2025 in Russian Journal of General Chemistry
Hybrid chalcones containing 1-hydroxyimidazole and chromene moieties were synthesized from 5-acetyl-1-hydroxyimidazoles and 3-formylchromenes. Application of DBU as a catalyst led to the mixtures of the target chalсones and intermediate aldols. Further interaction of the mixtures with 40% aqueous solution of sodium hydroxide in ethanol resulted in pure chalсones, isolated as trans-isomers. According to X-ray single crystal diffraction analysis, (E)-3-{3-[2-(4-fluorophenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]-3-oxoprop-1-en-1-yl}-6-methyl-4H-chromen-4-one exists as an N-hydroxyimidazole tautomer. Its planar structure is stabilized by the intramolecular hydrogen bond between the N-hydroxy group of the imidazole and the adjacent carbonyl group. The (E)-3-{3-[2-(4-fluorophenyl)-1-hydroxy-4-methyl-1H-imidazol-5-yl]-3-oxoprop-1-en-1-yl}-6-methyl-4H-chromen-4-one molecules in crystal were head-to-tail packed.